Genomics + AI Position
A precision medicine platform based on genomics and powered by AI
This company is becoming a pillar of modern U.S. healthcare. It is already deeply integrated into clinical workflows, widely used by leading pharmaceutical companies, and building a growing data advantage that very few businesses can realistically replicate.
Yet it remains underfollowed.
It trains its own AI models alongside companies like AstraZeneca, has FDA-approved AI diagnostics, is used by 95% of the top pharmaceutical companies, and has built a data moat that helps protect the business from even the largest AI labs. That makes the potential licensing or partnership catalyst particularly interesting.
Let’s dig in
Keep reading with a 7-day free trial
Subscribe to Daniel Romero to keep reading this post and get 7 days of free access to the full post archives.